Cargando…

Ph(+)急性淋巴细胞白血病ABL激酶区突变患者的临床、分子遗传学特征和治疗选择

OBJECTIVE: To clarify the clinical, cytogenetical and molecular characteristics and prognosis of Ph(+) ALL patients with ABL kinase domain mutations (ABL-KDMs), and to evaluate the therapeutic value of allogeneic hematopoietic stem cell transplantation (allo-HSCT) combined with tyrosine kinase inhib...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348204/
https://www.ncbi.nlm.nih.gov/pubmed/27014978
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.02.004